Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Equipment and Supplies × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 5 Head & Neck 4 Tumor-Agnostic 3 CNS 2 Plasma cell 1 Gynecologic 1 Gastrointestinal 1 Dermatologic 1

Conditions

Stomach Neoplasms 1 Esophageal Neoplasms 1

Interventions

Oxaliplatin 1423 Fluorouracil 1307 Capecitabine 1101 Gemcitabine 1046 Leucovorin 928 Bevacizumab 835 Irinotecan 823 Cisplatin 667 Radiotherapy 555 Cetuximab 478 pembrolizumab 434 Paclitaxel 396 Drug Therapy 352 Nivolumab 346 130-nm albumin-bound paclitaxel 323 Docetaxel 289 Sorafenib 288 S 1 (combination) 276 Albumin-Bound Paclitaxel 262 Folfox protocol 259 Surgical Procedures, Operative 252 lenvatinib 220 sintilimab 215 durvalumab 211 tislelizumab 209 regorafenib 207 Radiosurgery 203 apatinib 201 Magnetic Resonance Spectroscopy 199 Neoadjuvant Therapy 189

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04232735 2022-12-16

SOURCE

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase NA Unknown

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡